Coherus Oncology (CHRS) Treasury Shares (2012 - 2014)

Coherus Oncology has disclosed Treasury Shares across 3 years of filings, most recently posting $21.1 million for Q3 2014.

• In Q3 2014, Treasury Shares changed N/A year-over-year to $21.1 million; the TTM figure through Sep 2014 stood at $21.1 million (changed N/A YoY), while the FY2013 annual figure was $9.2 million, up 11.88% from the prior year.
• Treasury Shares came in at $21.1 million for Q3 2014 at Coherus Oncology, up from $9.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $21.1 million in Q3 2014 to a low of $8.2 million in Q4 2012.
• Average Treasury Shares over 3 years is $12.8 million, with a median of $9.2 million recorded in 2013.
• The largest YoY upside for Treasury Shares was 11.88% in 2013 against a maximum downside of 11.88% in 2013.
• Over 3 years, Treasury Shares stood at $8.2 million in 2012, then increased by 11.88% to $9.2 million in 2013, then soared by 130.84% to $21.1 million in 2014.
• Per Business Quant data, the three most recent Treasury Shares figures were $21.1 million in Q3 2014, $9.2 million in Q4 2013, and $8.2 million in Q4 2012.